An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis

Current Medical Research and Opinion

Volumn 23, Issue 7, 2007, Pages 1481-1491

  Wechowski, Jaroslaw ^a   Connolly, Mark ^b   Woehl, Anette ^a   Tetlow, Anthony ^a   McEwan, Phil ^a   Burroughs, Andrew ^c   Currie, Craig J ^d   Bhatt, Aomesh ^b  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b Ferring Pharmaceuticals AS   (Denmark)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Health economics; Liver; Oesophageal varices; Outcomes research; Vasoactive therapy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; OCTREOTIDE; PLACEBO; PROPRANOLOL; TERLIPRESSIN; VASOACTIVE AGENT;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ECONOMIC EVALUATION; ESOPHAGUS VARICES BLEEDING; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; LIVER CIRRHOSIS; MEDICAL RESEARCH; MORTALITY; PORTOSYSTEMIC ANASTOMOSIS; PROPHYLAXIS; PUBLICATION; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SALVAGE THERAPY; SENSITIVITY ANALYSIS; SURVIVAL; TREATMENT OUTCOME; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; DRUG COSTS; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; GREAT BRITAIN; HUMANS; LIVER CIRRHOSIS; LYSINE VASOPRESSIN; OCTREOTIDE; VASOCONSTRICTOR AGENTS;

EID: 34547180420     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X199736     Document Type: Article

References (43)

1. Gralnek IM, Jensen DM, Kovacs TO, et al. The economic impact of esophageal variceal hemorrhage: cost-effectiveness implications of endoscopic therapy. Hepatology 1999;29: 44-50
2. Kovacs T, Jensen D. Therapeutic endoscopy for upper gastrointestinal bleeding. In: Taylor M, Gollan J, Peppercorn M, Steer M, Wolfe M, eds. Gastrointestinal Emergencies. Baltimore: Williams & Wilkins, 2006:181-98
3. Laine L. Upper gastrointestinal tract hemorrhage. West J Med 1991;155:274-9
4. Rubenstein JH, Eisen GM, Inadomi JM. A cost-utility analysis of secondary prophylaxis for variceal hemorrhage. Am J Gastroenterol 2004;99:1274-88
5. Targownik LE, Spiegel BM, Dulai GS, et al. The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage. Am J Gastroenterol 2004;99:1306-15
6. McCormick PA, O'Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001;49: 682-5
7. Soares-Weiser K, Brezis M, Tur-Kaspa R, Leibovici L. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD002907
8. Nevens F. Review article: a critical comparison of drug therapies in currently used therapeutic strategies for variceal haemorrhage. Aliment Pharmacol Ther 2004;20 (Suppl 3):18-22
9. Ferguson JW, Tripathi D, Hayes PC. Review article: the management of acute variceal bleeding. Aliment Pharmacol Ther 2003;18:253-62
10. Harry R, Wendon J. Management of variceal bleeding. Curr Opin Crit Care 2002;8:164-70
11. Hui AJ, Sung JJ. Endoscopic treatment of upper gastrointestinal bleeding. Curr Treat Options Gastroenterol 2005;8:153-62
12. Sorbi D, Gostout CJ, Peura D, et al. An assessment of the management of acute bleeding varices: a multicenter prospective member-based study. Am J Gastroenterol 2003;98: 2424-34
13. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332-54
14. Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev 2003;(1):CD002147. Published in Aliment Pharmacol Ther 2003;17: 53-64
15. Yan BM, Lee SS. Emergency management of bleeding esophageal varices: drugs, bands or sleep? Can J Gastroenterol 2006;20:165-70
16. Gotzsche PC, Hrobjartsson A. Somatostatin analogues for acute bleeding oesophageal varices. Cochrane Database Syst Rev 2005;(1):CD000193
17. Zaman A. Current Management of Esophageal Varices. Curr Treat Options Gastroenterol 2003;6:499-507
18. Ingrand P, Gournay J, Bernard P, et al. Management of digestive bleeding related to portal hypertension in cirrhotic patients: a French multicenter cross-sectional practice survey. World J Gastroenterol 2006,12:7810-14
19. British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary 52. http://www.bnf.org/bnf [Last accessed 5 May 2006]
20. Levacher S, Letoumelin P, Pateron D, et al. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995;346:865-8
21. Curtis L, Netten A. Unit Costs of Health and Social Care 2005. Canterbury: Personal Social Services Research Unit, University of Kent at Canterbury 2005
22. Department of Health. NHS reference costs 2005. http://www.dh.gov.uk/ PublicationsAndStatistics/Publications/ PublicationsPolicyAndGuidance [Last accessed 28 June 2006]
23. Riley TR III, Bhatti AM. Preventive strategies in chronic liver disease: part II. Cirrhosis. Am Fam Physician 2001;64:1735-40
24. McCormick PA, Greenslade L, Matheson LA, et al. Vasoconstrictors in the management of bleeding from oesophageal varices. A clinico-economic appraisal in the UK. Scand J Gastroenterol 1995;30:377-83
25. Younossi ZM, Boparai N, McCormick M, et al. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol 2001;96:579-83
26. D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003;38:599-612
27. Chalasani N, Kahi C, Francois F, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003;98:653-9
28. Lay CS, Tsai YT, Teg CY, et al. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology 1997;25: 1346-50
29. HM Treasury. The Green Book: Appraisal and Evaluation in Central Government, Treasury Guidance. London: HM Treasury 2003
30. Continuous Mortality Investigation Bureau. Mortality rates and complete expectations of life from the PFA92(C=2010) and PMA92(C=2010) tables of mortality. http://www.actuaries.org.uk [Last accessed 17 Jan 2006]
31. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ 2004;329: 224-7
32. Combier E, Levacher S, Letoumelin P, et al. Cost-effectiveness analysis of the terlipressin-glycerin trinitrate combination in the pre-hospital management of acute gastro-intestinal haemorrhage in cirrhotic patients. Intensive Care Med 1999;25: 364-70
33. De Franchis R, ed. Portal Hypertension IV - Proceedings from the 4th Baveno International Consensus Workshop. Oxford: Blackwell Publishing 2006
34. Gold MR, Siegel JE, Russell LB. Cost-effectiveness in health and medicine. New York: Oxford University Press 1996
35. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Econ 2004;13:405-15
36. D'Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 2003;124: 1277-91
37. Gross M, Schiemann U, Muhlhofer A, Zoller WG. Meta-analysis: efficacy of therapeutic regimens in ongoing variceal bleeding. Endoscopy 2001;33:737-46
38. Triantos CK, Goulis J, Patch D, et al. An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy 2006;38:797-807
39. Rockey DC. Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices. Curr Gastroenterol Rep 2006;8:7-13
40. Kurstein P, Gluud LL, Willemann M, et al. Agreement between reported use of interventions for liver diseases and research evidence in Cochrane systematic reviews. J Hepatol 2005;43:984-9
41. Carbonell N, Pauwels A, Serfaty L, et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004;40:652-9
42. Ben-Ari Z, Cardin F, McCormick AP, et al. A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol 1999;31:443-50
43. Solanki P, Chawla A, Garg R, et al. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol 2003;18:152-6